NCT02849405View on ClinicalTrials.gov

Evaluation of the Capacity of a Camera to Identify Signs of Arteriosclerosis in Retinal Arterioles

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 21, 2016

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions
Arteriosclerosis
Interventions
DEVICE

MHRC: Metabolic Hyperspectral Retinal Camera

Comparison of hyperspectral signature of retinal arterioles between subjects suffering from arteriosclerosis and healthy control subjects.

Trial Locations (1)

H1T 1C8

Montreal Heart Institute, Montreal

All Listed Sponsors
collaborator

Montreal Heart Institute

OTHER

collaborator

Polytechnique Montréal

UNKNOWN

lead

Jean-Claude Tardif

OTHER

NCT02849405 - Evaluation of the Capacity of a Camera to Identify Signs of Arteriosclerosis in Retinal Arterioles | Biotech Hunter | Biotech Hunter